{
    "Trade/Device Name(s)": [
        "Chemtrue Single/Multi-Panel Drug Screen Cassette and Dip Card Tests",
        "Chemtrue Single/Multi-Panel Drug Screen Tests"
    ],
    "Submitter Information": "Chemtron Biotech, Inc.",
    "510(k) Number": "K111322",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061718"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JXM",
        "DIS",
        "DJC",
        "DJR",
        "DJG"
    ],
    "Summary Letter Date": "August 18, 2011",
    "Summary Letter Received Date": "August 19, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3170"
    ],
    "Regulation Name(s)": [
        "Benzodiazepine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzodiazepines",
        "Barbiturates",
        "Ecstasy (MDMA/XTC)",
        "Methadone",
        "Opiates (Morphine)",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Colloidal gold immunoassay"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Cassette",
        "Dip Card"
    ],
    "Document Summary": "FDA 510(k) summary for Chemtrue Single/Multi-Panel Drug Screen Cassette and Dip Card Tests for qualitative detection of six drugs of abuse in urine by lateral flow immunoassay.",
    "Indications for Use Summary": "Rapid lateral flow immunoassays for qualitative detection of up to six drugs (benzodiazepines, barbiturates, ecstasy, methadone, opiates, oxycodone) in human urine for in vitro diagnostic and prescription use only; provides preliminary results requiring confirmatory testing.",
    "fda_folder": "Toxicology"
}